Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Tuberculosis

  Free Subscription


Articles published in AIDS

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    May 2018
  1. SHAPIRO AE, Hong T, Govere S, Thulare H, et al
    C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001902.
    PubMed     Text format     Abstract available


    October 2017
  2. LACOURSE SM, Pavlinac PB, Cranmer LM, Njuguna IN, et al
    Stool Xpert MTB/RIF and urine lipoarabinomannan (LAM) for diagnosing tuberculosis in hospitalized HIV-infected children.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001662.
    PubMed     Text format     Abstract available


    August 2017
  3. WINTER JR, Stagg HR, Smith CJ, Brown AE, et al
    Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV from 2000 to 2014.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001635.
    PubMed     Text format     Abstract available


    July 2017
  4. BISSON GP, Ramchandani R, Miyahara S, Mngqibisa R, et al
    Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.
    AIDS. 2017 Jul 24. doi: 10.1097/QAD.0000000000001606.
    PubMed     Text format     Abstract available


    June 2017
  5. LECCA L, Galea J, Contreras CC, Millones AK, et al
    Challenges in tuberculosis/HIV management in a country with a concentrated HIV epidemic.
    AIDS. 2017;31:1207-1209.
    PubMed     Text format    


    January 2017

  6. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.
    AIDS. 2017;31:375-384.
    PubMed     Text format     Abstract available


    November 2016
  7. KUNKEL A, Crawford FW, Shepherd J, Cohen T, et al
    Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.
    AIDS. 2016;30:2715-2723.
    PubMed     Text format     Abstract available


    October 2016
  8. VAN DER WERF MJ, Kodmon C, Zucs P, Hollo V, et al
    Tuberculosis and HIV co-infection in Europe: looking at one reality from two angles.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    August 2016
  9. ALVAREZ H, Marino A, Garcia-Rodriguez JF, Vilas-Sueiro A, et al
    Immune reconstitution inflammatory syndrome in an HIV-infected patient using subcutaneous silicone fillers.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  10. HIRA S, Piot P
    The counter effects of the ebola epidemic on control and treatment of HIV/AIDS, tuberculosis, and malaria in West Africa.
    AIDS. 2016.
    PubMed     Text format    


    June 2016
  11. STERLING TR, Scott NA, Miro JM, Calvet G, et al
    Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.
    AIDS. 2016;30:1607-15.
    PubMed     Text format     Abstract available


    March 2016
  12. STERLING TR, Scott NA, Miro JM, Calvet G, et al
    Three months of weekly rifapentine plus isoniazid for treatment of M. tuberculosis infection in HIV co-infected persons.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  13. SUMNER T, Houben RM, Rangaka MX, Maartens G, et al
    Post-Treatment Effect of Isoniazid Preventive Therapy on Tuberculosis Incidence in Hiv-Infected Individuals on Antiretroviral Therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    January 2016
  14. MARAIS S, Meintjes G, Lesosky M, Wilkinson KA, et al
    Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis.
    AIDS. 2016;30:395-404.
    PubMed     Text format     Abstract available


  15. KARO B, Krause G, Hollo V, van der Werf MJ, et al
    The impact of HIV infection on treatment outcome of tuberculosis: analysis of surveillance data from nine European countries, 2010-2012.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  16. BOON SD, Matteelli A, Ford N, Getahun H, et al
    Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV: a systematic review and meta-analysis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    November 2015
  17. BACHMANN MO, Timmerman V, Fairall LR
    Effect of antiretroviral treatment on the risk of tuberculosis during South Africa's programme expansion.
    AIDS. 2015;29:2261-8.
    PubMed     Text format     Abstract available


    September 2015
  18. YOTEBIENG M, Edmonds A, Lelo P, Wenzi LK, et al
    High completion of isoniazid preventive therapy among HIV-infected children and adults in Kinshasa, Democratic Republic of Congo.
    AIDS. 2015;29:2055-7.
    PubMed     Text format     Abstract available


    August 2015
  19. GUPTA RK, Lucas SB, Fielding KL, Lawn SD, et al
    Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis.
    AIDS. 2015.
    PubMed     Text format     Abstract available


    July 2015
  20. JOSEPH JP, Jerome G, Lambert W, Almazor P, et al
    Going beyond the vertical: leveraging a national HIV quality improvement programme to address other health priorities in Haiti.
    AIDS. 2015;29 Suppl 2:S165-73.
    PubMed     Text format     Abstract available


    June 2015
  21. GUPTA RK, Brown AE, Zenner D, Rice B, et al
    CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  22. LIU E, Makubi A, Drain P, Spiegelman D, et al
    Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  23. RICHAUD C, Ghosn J, Amazzough K, Poiree S, et al
    Anti-tumor necrosis factor monoclonal antibody for steroid-dependent TB-IRIS in AIDS.
    AIDS. 2015;29:1117-9.
    PubMed     Text format    


    December 2014
  24. HARIDAS V, Pean P, Jasenosky LD, Madec Y, et al
    TB-IRIS and remodelling of the T-cell compartment in highly immunosuppressed HIV+ patients with TB: the CAPRI-T (ANRS-12614) study.
    AIDS. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: